A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19

The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark Klein MD, Vinh Dao PharmD, BCPS, Fatima Khan MD, MPH
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5edbd1c1c50a4406b493905b9187d87f
record_format dspace
spelling oai:doaj.org-article:5edbd1c1c50a4406b493905b9187d87f2021-11-11T00:33:25ZA Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-191938-272310.1177/10760296211051764https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f2021-11-01T00:00:00Zhttps://doi.org/10.1177/10760296211051764https://doaj.org/toc/1938-2723The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emphasizes the similarities between the physiological effects of platelet activating factor and the clinical complications of severe COVID-19.Mark Klein MDVinh Dao PharmD, BCPSFatima Khan MD, MPHSAGE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENClinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Mark Klein MD
Vinh Dao PharmD, BCPS
Fatima Khan MD, MPH
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
description The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emphasizes the similarities between the physiological effects of platelet activating factor and the clinical complications of severe COVID-19.
format article
author Mark Klein MD
Vinh Dao PharmD, BCPS
Fatima Khan MD, MPH
author_facet Mark Klein MD
Vinh Dao PharmD, BCPS
Fatima Khan MD, MPH
author_sort Mark Klein MD
title A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
title_short A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
title_full A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
title_fullStr A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
title_full_unstemmed A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
title_sort review of platelet-activating factor as a potential contributor to morbidity and mortality associated with severe covid-19
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f
work_keys_str_mv AT markkleinmd areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
AT vinhdaopharmdbcps areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
AT fatimakhanmdmph areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
AT markkleinmd reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
AT vinhdaopharmdbcps reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
AT fatimakhanmdmph reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19
_version_ 1718439587874865152